Search

everythinglearnresearchcommunity

for

Search:↓

Certain patient characteristics can help predict hair regrowth success with ritlecitinib in alopecia areata.

Kaempferol helps skin stem cells grow and may improve skin thickness due to its 3-OH group.

Removing STAT5 from 3D-cultured human skin cells reduces their ability to grow hair.

Ginsenoside Rd may help improve skin aging by increasing collagen in the skin.

Tofacitinib helped regrow hair in most patients with severe hair loss.

The summit aimed to speed up finding treatments for alopecia areata.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

3-Deoxysappanchalcone helps human hair cells grow and stimulates hair growth in mice by affecting certain cell signaling pathways.

Ritlecitinib successfully treated a child's alopecia universalis after baricitinib failed.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

Upadacitinib may cause hair loss.

Continuous baricitinib is needed to keep hair regrowth in severe alopecia areata.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

New alopecia treatments aim for better results and fewer side effects.

MSC-EVs and UCB-EVs improve skin wound healing and reduce scarring.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

The meeting highlighted important advances in stem cell research and its potential for creating new medical treatments.

The health of the gut may be important in developing new ways to prevent, diagnose, and treat alopecia areata.

Alopecia Areata is an autoimmune disease causing hair loss, with no cure yet, but research may lead to new treatments.

Including ineffective or unsafe doses in reviews can lead to misleading conclusions about alopecia areata treatments.

Biologic agents are effective for severe hidradenitis suppurativa when other treatments fail.

Tofacitinib effectively promotes hair regrowth in alopecia areata with minimal side effects.

Baricitinib is more effective than methotrexate for severe alopecia areata.

Calcipotriol's effectiveness for treating alopecia areata is unclear and needs more research.

Tofacitinib improved hair regrowth and quality of life in children with alopecia areata, with mild side effects.

New treatments offer hope for better managing hidradenitis suppurativa.